Aesthetic Medicine Market - By Type (Surgical Procedures, Non-surgical Procedures), Product (Energy-based, Non Energy-based), Gender (Male, Female), End-use (Hospitals, Beauty Centres & Medical Spas, Dermatology Clinics) - Global Forecast (2024

Description

Global Aesthetic Medicine Market size will record a 12% CAGR between 2024 and 2032, driven by innovations in treatments and devices coupled with streamlined approvals. Advances such as minimally invasive procedures, advanced laser technologies, and improved injectables are enhancing treatment efficacy and patient satisfaction. Furthermore, expedited regulatory processes are facilitating quicker market entry for innovations and expanding treatment options. These developments meet rising consumer expectations and attract more practitioners and investors, fostering market growth by offering safer, more effective solutions for aesthetic enhancements globally.

For instance, in June 2024, PeerJ, an acclaimed Open Access publisher, partnered with Agora, the Scientific Society of Aesthetic Medicine, and launched the Aesthetic and Regenerative Medicine Hub. This collaboration aims to foster innovative research and practical applications in these fields. It may attract more investment, spur the development of new procedures, and strengthen scientific foundations, thereby expanding the market's capabilities and appeal to both practitioners and patients worldwide.

The aesthetic medicine industry is segmented based on type, product, gender, end-use, and region.

The energy-based segment will see a notable surge by 2032 due to technological innovations in devices like lasers, radiofrequency, and ultrasound. These technologies offer effective solutions for skin rejuvenation, body contouring, and hair removal, catering to a growing demand for non-invasive and minimally invasive treatments. Increasing adoption of these energy-based devices by dermatologists and cosmetic surgeons underscores their clinical efficacy and patient satisfaction. With ongoing innovations enhancing treatment outcomes, the energy-based segment will dominate the aesthetic medicine market in addressing diverse aesthetic concerns globally.

The dermatology clinics segment will amass remarkable gains by 2032, owing to increasing patient preference for specialized care and personalized treatments. These clinics offer a wide range of cosmetic procedures, such as laser treatments, injectables, and skin rejuvenation therapies, catering to diverse aesthetic needs. Growing consumer trust in dermatologists' expertise and technological advancements in treatment options further boost this segment's prominence. As the demand for aesthetic enhancements continues to rise, dermatology clinics will play a pivotal role in shaping the market's growth trajectory.

Asia Pacific aesthetic medicine industry share will achieve a substantial CAGR from 2024 to 2032, fueled by rising disposable incomes, increasing awareness of aesthetic procedures, and advancing healthcare infrastructure. Countries like China, Japan, and South Korea are key contributors to this growth, supported by a growing elderly population and cultural emphasis on beauty and wellness. The region's expanding medical tourism sector further bolsters its market position. As demand for non-invasive procedures rises, Asia Pacific's prominence in the aesthetic medicine market will solidify in the coming years.

Product Code: 2687

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing awareness regarding aesthetic procedures
  - 3.2.1.2 Technological advancements associated with medical aesthetic devices
  - 3.2.1.3 Rising prevalence of obesity
  - 3.2.1.4 Increasing adoption of non-invasive procedures
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with aesthetic procedures
  - 3.2.2.2 Lack of reimbursement and stringent regulatory scenario
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn, Units)

5.1 Key trends
5.2 Surgical
5.3 Non-surgical

Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn, Units)

6.1 Key trends
6.2 Energy-based
- 6.2.1 Laser-based aesthetic device
- 6.2.2 Radiofrequency (RF)-based aesthetic device
- 6.2.3 Light-based aesthetic device
- 6.2.4 Ultrasound aesthetic device
- 6.2.5 Other energy-based products
6.3 Non energy-based
- 6.3.1 Botulinum toxin
- 6.3.2 Dermal fillers
- 6.3.3 Implants
  - 6.3.3.1 Facial implants
  - 6.3.3.2 Breast implants
  - 6.3.3.3 Other implants
- 6.3.4 Others non energy-based products

Chapter 7 Market Estimates and Forecast, By Gender, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Male
- 7.2.1 18 years and below
- 7.2.2 19-34 years
- 7.2.3 35-50 years
- 7.2.4 51-64 years
- 7.2.5 65 years and above
7.3 Female
- 7.3.1 18 years and below
- 7.3.2 19-34 years
- 7.3.3 35-50 years
- 7.3.4 51-64 years
- 7.3.5 65 years and above

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Beauty centers and medical spas
8.5 Dermatology clinics
8.6 Home settings

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn, Units)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Malaysia
- 9.4.7 Singapore
- 9.4.8 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 Apax Partners
10.2 Boston Scientific Corporation
10.3 Bausch Health Companies Inc
10.4 El.En. S.p.A.
10.5 GC Aesthetics plc
10.6 Huadong Medicine Co., Ltd.
10.7 Johnson & Johnson
10.8 Merz Pharma
10.9 Sciton, Inc.
10.10 SharpLight Technologies Inc.
10.11 Sisram Medical Ltd
10.12 Vitruvian Partners LLP

Aesthetic Medicine Market - By Type (Surgical Procedures, Non-surgical Procedures), Product (Energy-based, Non Energy-based), Gender (Male, Female), End-use (Hospitals, Beauty Centres & Medical Spas, Dermatology Clinics) - Global Forecast (2024 - 2032)